Test Price
4,600 AED✅ Home Collection Available
OncoPro Focus Fusion Panel for Solid Tumors – 4,600 AED | DNA Labs UAE
Executive Summary & Core Metrics
Achieve unmatched diagnostic clarity with the OncoPro Focus Fusion Panel, featuring 99.9% diagnostic sensitivity through ISO 9001:2015 certified next-generation sequencing. This panel detects clinically actionable gene fusions in solid tumors, guiding targeted therapy decisions. Service includes Secure Medical Courier Solid Tissue Specimen Retrieval of archived FFPE tumour blocks, telephonic post-test clinical guidance by a DHA-licensed specialist, and direct insurance billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The OncoPro Focus Fusion Panel is a comprehensive molecular diagnostic assay that uses next-generation sequencing (NGS) to detect fusion genes across multiple solid tumour types. It provides oncologists with critical information to select targeted therapies, predict prognosis, and monitor treatment resistance – all from a single FFPE tumour block.
| Feature | Our Test – OncoPro Focus Fusion Panel | Standard Single-Gene FISH |
|---|---|---|
| Precision & Sensitivity | 99.9% diagnostic sensitivity; detects known and novel fusions | ~85% sensitivity for one gene; limited to pre-specified breakpoints |
| Methodology | NGS with bioinformatics (LC‑MS/MS-free) and ISO 9001:2015 validated pipeline | Fluorescence in situ hybridisation, often manual readout |
| Turnaround Time | 15 working days from Monday 11:00 AM sample receipt | Up to 21 calendar days |
| Therapy Guidance | Fully annotated fusion report linked to approved & investigational targeted drugs | Binary positive/negative; no therapeutic context |
Physician Insight & Safety Protocols
“As a clinician treating patients across the UAE, I rely on the OncoPro Focus Fusion Panel because it transforms a complex genomic landscape into a clear therapeutic roadmap. Every result must be interpreted alongside the patient’s full clinical and imaging data – there is no substitute for the doctor‑patient relationship. I personally remind each patient: a single molecular report does not replace compassionate, holistic oncology care.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA License No. 61713011
⚠️ Medication Advisory
Do not discontinue or modify any prescribed medication, including targeted therapy, without consulting your oncology specialist. Altering treatment solely based on a genetic test may lead to disease progression or serious adverse events.
🛑 Patient Safety & Exclusion Criteria
- Block must contain ≥10% viable tumour tissue; specimens with extensive necrosis or poor fixation are rejected.
- Decalcified samples (e.g., bone biopsies treated with strong acids) compromise nucleic acid integrity and cannot be processed.
- Children & adolescents: testing ordered only with written parental/legal guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Currently hospitalised patients or those with febrile neutropenia: defer elective testing and seek immediate ER evaluation.
🚨 Emergency Red Flags: Seek urgent medical attention if you experience new severe pain, difficulty breathing, high fever, or uncontrolled bleeding while awaiting results. Molecular testing does not replace acute medical care.
Patient FAQ & Clinical Guidance
1. What exactly does the OncoPro Focus Fusion Panel detect, and how can it change my treatment?
The panel identifies actionable gene fusions with 99.9% diagnostic sensitivity, guiding precise targeted cancer therapy choice. It looks for abnormal joining of two genes that drive tumour growth, revealing which FDA/EMA-approved drugs or clinical trial options are likely to work best for your specific cancer.
2. How do I prepare for the sample collection, and is it painful?
No special patient preparation is needed; our Secure Medical Courier Solid Tissue Specimen Retrieval service collects the archived FFPE tumour block from your chosen location. The process is painless – you simply provide the tissue block originally obtained during your biopsy or surgery, and we handle all cold‑chain transport to the lab.
3. Will my health insurance cover the cost of this test?
Most UAE insurance plans cover the OncoPro Focus Fusion Panel when preauthorised; we provide direct billing verification within 60 minutes via WhatsApp. Send your policy number to +971 54 548 8731, and our team confirms coverage and any out‑of‑pocket amount before proceeding.
UAE Regulatory & Data Privacy Adherence
This service strictly adheres to UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is processed in a secure, ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139) with end-to-end encryption. The facility operates under DHA Facility License No. 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | OncoPro Focus Fusion Panel for Solid Tumors |
| Price (AED) | 4,600 |
| Turnaround Time | 15 working days from sample receipt |
| Sample Type / Matrix | FFPE tumour block (archival solid tissue) |
| Methodology Used | Next-Generation Sequencing (NGS) with bioinformatics pipeline; ISO 9001:2015 validated |
| ICD-10-CM Code | C80.9 |
| LOINC Code | 92878-8 |
| DHA Facility License & Laboratory Address | DNA Labs UAE | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians